The iWalk Story

History has shown that in wartime, research dollars are invested in research to advance technologies designed to improve function in impaired or amputated limbs.  Not surprisingly, great innovations are achieved during such times of focused research effort.  This era is no exception.  Beginning in 2003, when our men and women of the armed forces began suffering limb impairments and amputations in the Iraq and Afghanistan conflicts, the U.S. Government committed tens of millions of research dollars to visionaries, universities,  and manufacturers to ensure that our wounded soldiers received the best technology available.

Hugh Herr, PhD and Director of Biomechatronics at MIT was one of the visionaries who received funding in support of his lifelong quest to help people with limb pathology to move naturally. He applied these funds to a Powered Human Augmentation project. The result was the BiOM by iWalk, a leg system that replaces the combined functions of the foot, ankle and calf regions of the human body. It is the culmination of Dr. Herr’s years of research, engineering and clinical testing–and it is clinically available now.  The BiOM by iWalk has been shown to replicate the normal function of the human leg, thus restoring normalization to almost 100%. 

With funding provided by the U.S. Department of Veterans Affairs, and the Army’s Telemedicine and Advanced Technology Research Center (TATRC), Dr Herr and  collaborators diligently sought an ideal in human-machine interaction.  Today the BiOM by iWalk has been clinically shown to be the only prosthetic system to reach human normalization, allowing amputees to walk as if their legs were biological once again.

The BiOM by iWalk is the first in a series of products that will  emulate or even augment physiological function through electromechanical replacement.  The commercialization of true bionic products by iWalk is underway.

Following are iWalk’s guiding principles:


Mission


We will use advanced bionics to emulate, or even augment, physiological function in people with limb pathology for the improvement of their quality of life

Vision

To become the leader of  bionic technology that has the transformative effect of changing physical disability into ability. 

Company Values

Integrity

Excellence

Determination